N-(2-aminocycloheptyl)alkanoylanilides

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260455A, 260557R, 260562A, 260562R, 424311, 560 27, A61K 3122, A61K 31165, C07C15503, C07C15707

Patent

active

041691563

ABSTRACT:
N-(2-aminocycloheptyl)N-alkanoylanilides and their 2-N-oxides of the formula ##STR1## e.g., trans-3,4-dichloro-N-[2-(allylamino)cycloheptyl]propionanilide, and their pharmacologically acceptable salts, have been found to possess potent Central Nervous System antidepressant properties. Many of them are new.
These compounds are promising antidepressant drugs which are characterized by lower toxicity than imipramine, and long acting activity which may allow longer durations between administrations, e.g., once a day. Pharmaceutical compositions containing these compounds and a process for treating conditions of depression with these compositions are disclosed.

REFERENCES:
patent: 3510492 (1970-05-01), Szmuszkovicz

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N-(2-aminocycloheptyl)alkanoylanilides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-(2-aminocycloheptyl)alkanoylanilides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(2-aminocycloheptyl)alkanoylanilides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1986147

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.